tiprankstipranks
The Fly

Adma Biologics options imply 13.3% move in share price post-earnings

Adma Biologics options imply 13.3% move in share price post-earnings

Pre-earnings options volume in Adma Biologics (ADMA) is 1.5x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 13.3%, or $2.63, after results are released. Median move over the past eight quarters is 8.8%.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com